Sorry, you need to enable JavaScript to visit this website.
This website is intended only for Healthcare Professionals.

Obesity

Obesity

By 2030, obesity could affect more than half of the US population.1

Obesity is often an underlying issue behind several of the most common costly, and potentially deadly, health conditions.2Evidence shows that a decrease in BMI reduces annual medical expenditures and is likely to result in clinically meaningful health benefits.3

At Nestlé Health Science, we are actively engaged in developing nutritional therapies to help reduce obesity and its associated comorbidities, while improving the quality of life of those who are challenged by the condition. 

Discover More

Obesity

Obesity

By 2030, obesity could affect more than half of the US population.1

Obesity is often an underlying issue behind several of the most common costly, and potentially deadly, health conditions.2Evidence shows that a decrease in BMI reduces annual medical expenditures and is likely to result in clinically meaningful health benefits.3

At Nestlé Health Science, we are actively engaged in developing nutritional therapies to help reduce obesity and its associated comorbidities, while improving the quality of life of those who are challenged by the condition. 

Discover More

Obesity
> Videos

Results
4

Non-alcoholic fatty liver disease (NAFLD) is the most common liver condition worldwide, affecting approximately 25% of the population worldwide. NAFLD is an umbrella term which encompasses a spectrum of conditions that ranges from steatosis to nonalcoholic steatohepatitis (NASH) to cirrhosis. It is characterized by the presence of excessive hepatic fat accumulation ­5% and associated with metabolic abnormalities including obesity, type 2 diabetes (T2DM), insulin resistance, and cardiovascular disease.

Watch now

Objectives:
• State relevant epidemiologic data and risk factors for NAFLD and NASH
• Describe screening, diagnosis and treatment options for patients with a diagnosis of NAFLD
• Discuss current evidence around weight management for a patient diagnosed with NAFLD or NASH

This recording does not offer CE.

Watch now
Diagnosis and Management of NAFLD and NASH
Date:
Duration:
60
min